Evidence map›Paper›PMID 37700486›Full record

ArticleClinical and translational medicine2023

Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.

Tingwei Zhang, Yu Wei, Boon Hao Hong, Takayuki Sumiyoshi, Enya Hui Wen Ong, Hao Zeng, Yonghong Li, Chi-Fai Ng, Jian Pan, Bangwei Fang and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tingwei ZhangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yu WeiDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Boon Hao HongDivision of Medical Sciences, National Cancer Centre Singapore, Singapore.
Takayuki SumiyoshiDepartment of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Enya Hui Wen OngDivision of Medical Sciences, National Cancer Centre Singapore, Singapore.
Hao ZengDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Yonghong LiDepartment of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Chi-Fai NgDepartment of Surgery, and SH Ho Urology Center, Chinese University of Hong Kong, Hong Kong, Hong Kong.
Jian PanDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Bangwei FangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Beihe WangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Junlong WuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Hongkai WangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Shusuke AkamatsuDepartment of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Melvin Lee Kiang ChuaDivision of Medical Sciences, National Cancer Centre Singapore, Singapore.
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yao ZhuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0001-7950-6669

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NomogramsProstatic NeoplasmsDNA DamageGerm CellsHumansMale

Identifiers

PMID37700486
PMCPMC10497832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.